Drug intelligence / Profile preview

Jinfo Zhitong Wan

Development stage
Unknown
Lead developer
Guangzhou Baiyunshan Zhongyi Pharmaceutical
Administration
Oral
01

Overview

Jinfo Zhitong Wan (金佛止痛丸) is an approved traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Guangzhou Baiyun Mountain Zhongyi Pharmaceutical Co., Ltd. (formerly Guangzhou Zhongyi Pharmaceutical Co., Ltd.). This oral medication is indicated for the treatment of various pain conditions, including stomachache, dysmenorrhea (menstrual pain), peptic ulcer, and chronic gastritis. According to TCM principles, the formulation functions by promoting the circulation of vital energy (Qi), relieving pain, soothing the liver, and regulating the stomach. It is a multi-herb formulation administered orally, typically at a dosage of 5-10 grams, 2-3 times per day during pain episodes. It is contraindicated in pregnant women and those with menorrhagia.

Brand names
Jinfo Zhitong Wan
Other names
Jinfo pain-relieving pills金佛止痛丸
02

Targets

MMP1 (Matrix metalloproteinase-1)MMP9 (Matrix metalloproteinase-9)MMP3 (Matrix metalloproteinase-3)

Beyond the preview

Go deeper on Jinfo Zhitong Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinfo Zhitong Wan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call